This pack has been prepared ahead of the debate to be held in Westminster Hall at 1.30pm on Thursday 23 May 2019 on supporting clinical trials and the UK’s future clinical research capability. The subject for the debate has been selected by the Backbench Business Committee and the debate will be opened by Chris Green MP.
Commons Library debate pack - Supporting clinical trials and the UK’s future clinical research capability (467 KB , PDF)
There will be a debate in Westminster Hall on Thursday 23 May 2019 on supporting clinical trials and the UK’s future clinical research capability. The subject for the debate has been selected by the Backbench Business Committee and the debate will be led by Chris Green MP.
Commons Library debate pack - Supporting clinical trials and the UK’s future clinical research capability (467 KB , PDF)
The Infected Blood Public Inquiry recommended that the government should set up a compensation scheme for those infected and affected by contaminated blood, blood products and tissue. The government accepted this recommendation and made regulations to establish the Infected Blood Compensation Scheme in August 2024.
The NHS will pay a subscription fee to pharmaceutical companies, which will give it access to new antimicrobial drugs for drug-resistant infections.
Antimicrobial resistance (AMR) is a significant threat to public health. This briefing provides information on the causes and implications of the development and spread of AMR and about UK and international action to address it.
